China Biologic Products Holdings, Inc.
CBPO
CBPO was delisted on the 20th of April, 2021.
21 hedge funds and large institutions have $345M invested in China Biologic Products Holdings, Inc. in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
26% more capital invested
Capital invested by funds: $273M → $345M (+$72M)
17% more funds holding
Funds holding: 18 → 21 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LBA
Letko, Brosseau & Associates
Montreal,
Quebec, Canada
|
+$820K |
| 2 |
ACM
Ativo Capital Management
Chicago,
Illinois
|
+$567K |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
+$399K |
| 4 |
Invesco
Atlanta,
Georgia
|
+$340K |
| 5 |
Renaissance Technologies
New York
|
+$242K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PP
PDT Partners
New York
|
-$563K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$471K |
| 3 |
Morgan Stanley
New York
|
-$349K |
| 4 |
SIM
Spark Investment Management
New York
|
-$292K |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$87.1K |
CBPO Hedge Fund Activity: Q3 2013 in Review
21 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in China Biologic Products Holdings, Inc. (CBPO) for Q3 2013, worth a combined $345M — up 26% from $273M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CBPO positions and 2 closed out — a net gain of 3 holders — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Letko, Brosseau & Associates, opening a new position worth an estimated $820K. The largest seller was PDT Partners, exiting entirely with an estimated $563K sold.
- 21 institutional investors held China Biologic Products Holdings, Inc. (CBPO) as of Q3 2013, up from 18 in Q2 2013.
- Funds reported $345M of China Biologic Products Holdings, Inc. stock for Q3 2013, up 26% quarter-over-quarter.
- 5 funds opened new China Biologic Products Holdings, Inc. positions in Q3 2013 and 2 closed out, a net change of +3 holders.
- The largest China Biologic Products Holdings, Inc. buyer in Q3 2013 was Letko, Brosseau & Associates, an estimated $820K added.
- The largest China Biologic Products Holdings, Inc. seller in Q3 2013 was PDT Partners, an estimated $563K sold.
Based on aggregated 13F filings for Q3 2013.